Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistAmarillo Snuff Co. was cited for manufacturing and distributing smokeless nicotine products without required premarket authorization, in violation of the Federal Food, Drug, and Cosmetic Act. The company's website offered these tobacco products for sale in the United States without securing the necessary "new tobacco product" authorization orders mandated by FDA regulations. The warning specifically noted that under 2022 legislation, FDA's jurisdiction expanded to include products containing nicotine from any source, requiring all such products to comply with applicable FD&C Act requirements before commercial marketing.